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The Mediterranean fruitfly Ceratitis capitata (medfly) is an invasive agricultural pest of high economic 
impact and has become an emerging model for developing new genetic control strategies as an 
alternative to insecticides. Here, we report the successful adaptation of CRISPR-Cas9-based gene 
disruption in the medfly by injecting in vitro pre-assembled, solubilized Cas9 ribonucleoprotein 
complexes (RNPs) loaded with gene-specific single guide RNAs (sgRNA) into early embryos. When 
targeting the eye pigmentation gene white eye (we), a high rate of somatic mosaicism in surviving G0 
adults was observed. Germline transmission rate of mutated we alleles by G0 animals was on average 
above 52%, with individual cases achieving nearly 100%. We further recovered large deletions in the 
we gene when two sites were simultaneously targeted by two sgRNAs. CRISPR-Cas9 targeting of the 
Ceratitis ortholog of the Drosophila segmentation paired gene (Ccprd) caused segmental malformations 
in late embryos and in hatched larvae. Mutant phenotypes correlate with repair by non-homologous 
end-joining (NHEJ) lesions in the two targeted genes. This simple and highly effective Cas9 RNP-
based gene editing to introduce mutations in C. capitata will significantly advance the design and 
development of new effective strategies for pest control management.
The Mediterranean fruitfly Ceratitis capitata (medfly) is an economically relevant agricultural pest infest-
ing more than 260 crop species including fruits, vegetables, and nuts1. Wild populations can be contained by 
the Sterile Insect Technique (SIT), an eradication strategy based on the repeated release of large numbers of 
factory-grown sterile males into infested areas2, 3. C. capitata was the first non-Drosophilidae insect species in 
which transposon-mediated germline transformation was established4, 5. Various transgenic strains have been 
developed to improve SIT and other pest control strategies6–14. Furthermore, embryonic RNA interference was 
successfully applied to study in vivo functions of key Ceratitis genes controlling sex determination15, 16.
Nonetheless, a more comprehensive study of gene functions in Ceratitis will be needed to further improve 
existing control strategies. To generate long-lasting and heritable changes in gene function, the novel 
CRISPR-Cas9 gene editing system with its modular and simple components provides a promising tool for reverse 
genetics also in insects and to implement scalable and reproducible pest control strategies17, 18. In short, Cas9 
endonuclease recognizes a specific genomic region based on sequence complementary of a preassembled chi-
meric single guide RNA (sgRNA), and induces double-strand DNA breaks (DSBs) at the targeted site. DSBs 
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activate non-homologous end-joining (NHEJ) or homology-directed (HR) DNA repair, two cellular events which 
can be exploited not only to disrupt genes but also to modify sequences after a given DNA template is provided 
or to introduce exogenous sequences19, 20.
In the model insect Drosophila melanogaster, the successful use of the Cas9 system to introduce genome mod-
ifications was based on injecting different combinations of CRISPR-Cas9 reagents into embryos, such as (1) DNA 
plasmids expressing Cas9 protein and sgRNA21, (2) DNA plasmid transcribing sgRNA (or in vitro synthesized 
sgRNA) into transgenic flies that express Cas9 in the embryonic germ line22–24 and (3) in vitro-transcribed Cas9 
mRNA and sgRNA25, 26. Furthermore, transgenic Drosophila strains have been generated that express both Cas9 
and sgRNA and can induce a variety of genetic effects beyond the mere gene editing27.
The efficiencies of these different application modes have been tested over the past few years. For instance, 
injections of purified Cas9 protein preloaded with trRNA, trans-activating RNA and gene-specific crRNA into 
Drosophila embryos yielded biallelic mutations in more than 8% and germ line transmission in more than 17% 
of the injected individuals28. The model lepidopteran Bombyx mori was the first non Drosophilidae insect species 
in which CRISPR-Cas9, applied co-injecting mRNA/sgRNAs, was shown to be highly effective also in inducing 
large deletions (95% somatic G0 mutants and 36% germ line transmission rate)29. In the mosquito Aedes aegypti, 
injections of preassembled RNPs with commercially purified Cas9 produced detectable lesions in 50% of injected 
individuals and germline transmission rate was 90%30. Furthermore, this study demonstrated that sgRNAs were 
more effective than the dual component system with crRNA and trRNA.
Altogether the use of CRISPR-Cas9 for gene editing was shown to be effective in more than two dozen 
arthropod species, belonging to 6 different orders (Diptera, Lepidotera, Coleoptera, Orthoptera, Decapoda 
and Diplostraca)18, 31, 32. In most of these studies, the preferred approach was to deliver mRNA encoding Cas9 
together with synthetic gRNAs (or produced by a U6-Promoter DNA plasmid). A drawback of this method is 
that, because of the extended time needed for Cas9 translation, folding and interaction with gRNAs, only divid-
ing cells that accumulate sufficient levels RNPs can be efficiently targeted. Injecting commercially available Cas9 
protein instead of mRNA yielded higher rates of NHEJ mediated lesions in Aedes aegypti30, 33, in three Anopheles 
species (Anopheles albimanus, Anopheles coluzzii, and Anopheles funestus)34 and in three lepidopteran species 
(Vanessa carduii, Junonia coenia and Papilio xuthus)35, 36. Lab-purified recombinant Cas9 was also very effective 
in generating mutants in the crop pest moth Spodoptera littoralis, resulting in mono/biallelic mutations in 90% of 
the injected G0 generation and germline transmission rate was 43%37.
The objectives of our study were to provide a protocol for production and purification of recombinant Cas9 
protein and to demonstrate that injecting RNPs results in highly efficient gene disruption in the major agricultural 
pest C. capitata. We decided on the strategy of injecting Cas9 RNPs into Ceratitis embryos for the following rea-
sons: (1) lab-produced Cas9 protein is cheaper than commercially available protein and also more cost-effective 
than the use of in vitro synthetized Cas9 mRNA28, 37, 38; (2) preloaded Cas9 RNPs can act immediately following 
injection33, 34 and this often results in higher efficiencies of inducing biallelic mutations in both somatic and 
germline cells28, 33, 34, 38; (3) there are potentially less off-target events37, 39, 40; (4) Cas9 protein is more stable and 
robust than synthetic Cas9 mRNA, and (5) a genetic strategy free of exogenous DNA in pest control management 
will be more acceptable avoiding contentious regulatory issues18, 31.
To test the feasibility of Cas9-mediated gene disruption in the medfly, we targeted the Ceratitis orthologues 
of white and paired genes, which in D. melanogaster are required for eye pigmentation4, 5, 41 and for embryonic 
segmentation42, 43, respectively.
The we gene is an ideal target to test Cas9-mediated disruption for the following reasons: (1) we function is 
cell-autonomous and unpigmented mutant cells can be readily detected in the adult eye; (2) a we mutant Ceratitis 
strain (w1/w1)41 is available to test new loss-of-function alleles for complementation. The zygotic activity of the 
Drosophila paired gene (prd) is required for proper segmentation of the developing embryo42. Drosophila embryos 
homozygous for prd loss-of-function alleles lack every other segment and die before hatching (pair-rule pheno-
type)42. Early segmentation is a well-conserved process in higher dipterans43, 44; we therefore hypothesized that 
somatic lesions in the prd ortholog (Ccprd; Genbank JAB89073.1) will result in comparable segmental defects and 
early larval lethality in Ceratitis.
Here, we show that lab-purified recombinant Cas9 protein in vitro pre-assembled with sgRNA is highly effec-
tive at inducing mono- and bi-allelic lesions in both somatic and germline cells. Our results also confirm a con-
served function of the Ccprd in proper embryonic segmentation.
Results
Cas9-induced somatic disruption of the we gene. We produced our own supply of Cas9 endonuclease 
by expressing and purifying HIS tagged recombinant protein from Escherichia coli28, following a customary puri-
fication protocol which is described in detail in the material and method section45, 46. We used the CHOPCHOP 
software47 to identify potential Cas9 target sequences in we and to design three independent sgRNAs, we-g1, 
we-g2, and we-g3 (Fig. 1A). Injections with unloaded recombinant Cas9 protein caused an almost twofold lower 
survival rate (15–18%, respectively with 0.9 and 3.6 μg/μl Cas9) compared to buffer alone injections (30%), sug-
gesting a measurable level of toxicity of Cas9 protein in Ceratitis embryos (Supplementary Table 1). In contrast, 
an intermediate Cas9 concentration showed higher survival rate similar to the one with only buffer (28%). We 
cannot exclude that also differences in the technical execution of the embryos microinjections added further 
variability. A slightly more pronounced toxicity of purified Cas9 was observed during transition from larvae to 
pupae (survival rates: 37–49% compared to 84%).
We next loaded recombinant Cas9 protein with individual sgRNAs in vitro (Cas9 1.8 μg/μl and gRNAs 0.2 μg/
μl) and injected the RNP complexes into early syncytial embryos of the wildtype Benakeion strain. We aimed at 
targeting syncytial nuclei to maximize the efficiency of inducing NHEJ lesions. A biallelic hit (we is autosomal in 
Ceratitis) at this early stage is expected to produce large clones of mutant tissue in injected individuals28, 34, 37–39. 
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In a first experiment, we injected we-g1 RNPs in a buffer containing 300 mM KCl to improve solubilization of 
Cas9, as previously established to achieve maximal Cas9 activity in zebrafish39. Of 240 injected embryos, 134 
larvae hatched and only 6 survived to adulthood (Supplementary Table 2). Such a low survival rate was due to 
technical problems related to this specific set of injections and larvae rearing. Three out of six (50%) displayed a 
mosaic pattern of white unpigmented ommatidia surrounded by wild-type pigmented ones (Fig. 1B–D). One of 
the two eyes in one individual was completely white, suggesting that a biallelic gene disruption event occurred 
at an early stage in the primordial lineage (Fig. 1C). The presence of mutations was confirmed by sequencing of 
PCR products spanning the cleavage sites. Direct sequencing of amplified genomic DNA showed heterogeneity 
in nucleotide calls around the cleavage site close to the protospacer-adjacent motif (PAM) site, consistent with 
a range of different NHEJ-induced alterations. Genomic we PCR products were obtained from pools of injected 
larvae or single adult G0 flies. Indels, mostly deletions, of variable length (Fig. 1E; we-g1, 14–21 bp), were detected 
in cloned fragments, consistent with previous studies17, 18. Embryos injections with we-g2 (150 mM KCl), and 
we-g3 (300 mM KCl) led to 13 and 10% adult survival rates, respectively, and to a lower percentage of adults with 
eye pigmentation mosaicism (4% for we-g2) or none (we-g3) (Supplementary Table 2).
Injections of we-g1 + we-g2 RNPs (150 mM KCl) led to 23% adult mosaics (Supplementary Table 2), but this 
duplex RNP targeting did not produce deletions between the two targeted sites which are 96 bp apart; further-
more, only we-g2 induced indels were observed (reported in Fig. 1E) (Supplementary Table 2). Again, sequencing 
of cloned PCR products revealed NHEJ deletions, ranging from 2–21 bp, in proximity to the PAM site of we-g2. 
Three additional rounds of injections of we-g1/we-g2 into a total of 600 embryos (data not shown), raising the 
buffer to 300 mM KCl, confirmed the lack of deletions between the two targeted sites by PCR analysis on genomic 
DNA from pools of larvae. When injecting simultaneously we-g2 and we-g3 RNPs (in 300 mM KCl) in early 
Figure 1. CRISPR-Cas9 targeting of we gene. (A) A scheme of the genomic organization of the we gene and 
the 3 sgRNAs targeted sites (denoted we-g1, we-g2, we-g3) (B) wildtype we+/we+ (left) and mutant we (w1/
w1)41 individual (right). (C) and (D) examples of somatic we clones in the eyes of G0 individuals. (E) Sequences 
of mutant we alleles recovered from G0 individuals targeted with we-g1 or we-g2. The CrispRVariants plots67 
show sequence composition of various alleles compared to reference (target sequence and PAM are boxed and 
position of cut site is indicated with a black line). The label of individual allele denotes the location (relative 
to the cut site) and the size of the deletion. Number of sequenced clones per allele are shown in the yellow 
box. (F) Sequences of mutant we alleles in G0 individuals targeted with duplex we-g2 and we-g3 RNPs. The 
CrispRVariants plot shows the spectrum of induced deletions in G0 individuals. Black lines indicate the position 
of the cut site in each target sequence (black boxes). >symbol signifies absence of mapped sequence from a 
partial alignment.
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embryos, we did recover deletions spanning the 2 more distant targeted sites, which are 436 bp apart. 9 deletions 
events ranging from 304 bp to 651 bp were observed by cloning and sequencing (Fig. 1F).
Cas9-induced germ line disruption of the we gene. To test for germline transmission of Cas9-induced 
we alleles, 9 injected G0 red eyed flies (3 we-g1 RNP- and 6 we-g2 RNP-injected flies; Supplementary Table 3) 
were individually crossed with we-mutant partners (carrying w1 alleles having a frameshift mutation in the 
sixth exon41; GenBank AH010565.2). Seven injected flies sired G1 progeny, six of which gave rise to mutant 
white eye flies (Fig. 2A), with a highly variable transmission rate (1.5–100%, on average 52%; Supplementary 
Table 3). Non-complementation of the CRISPR-Cas9-induced mutations confirms that they are allelic to the 
original we mutation (Fig. 2A). Of the three we-g1 injected individuals, two males sired small batches of prog-
eny in which 100% (we-g1#1; 6 flies) and 45% (we-g1#2; 10 out of 22), respectively, displayed the mutant phe-
notype (Supplementary Table 3). Of the six we-g2 injected individuals, 4 males produced various proportions 
of G1 mutant white-eyed progeny. Remarkably, the we-g1#1 and we-g2#5 lines gave rise to 100% and 98% G1 
white-eyed offspring, respectively (Supplementary Table 3).
Figure 2. CRISPR induced we non-complementing alleles transmitted to the G1 progeny. (A) homozygous 
wildtype we+ individual (left), homozygous mutant individual we (middle), G1 individual heterozygous for 
mutant we and CRISPR induced we mutation. (B) CrispRVariants plots of G1 mutant progeny of G0 targeted by 
we-g1 (3 sequences), targeted by we-g2 (1 sequence), we-g3 (6 sequences) or we-g2 + g3 (4 sequences).
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We randomly chose 4 out of 16 (6 + 10) G1 we-g1 mutant flies (two from we-g1#1 cross and two from we-g1#2 
cross) and 2 out of 166 (53 + 113) we-g2 mutant G1 flies (one from we-g2#4 line and one from we-g2#5 line) 
(Supplementary Table 3). Sequencing of cloned PCR products revealed that the 4 we-g1 G1 flies inherited one 
allele from the we parent and three different weCRISPR alleles from the injected G0 fathers. We found an identical 
we deletion of 14 bp (labeled “−3:14D” in Figs 1E and 2B) in both analyzed flies from the we-g1#2 cross, sug-
gesting that they inherited the same mutation from their common male founder (Fig. 2B: we-g1). Mutant G1 
flies of the we-g1#2 line carried two different alleles (4 bp and 10 bp deletions; −4:4D and −5:10D, respectively). 
All three Cas9-induced alleles are small deletions, causing frame-shifts in exon 2 of the we coding region, and 
failed to complement the original we mutation. Two we-g2 targeted G1 mutant flies carried two novel alleles, 
one with a 4 bp deletion (we-g2#4 line; Supplementary Table 3) and one with a long 84 bp deletion (we-g2#5 line; 
Supplementary Table 3) (Fig. 2B: we-g2; 84 bp deletion not shown).
To study genes for which no mutant alleles are available, it may be useful to screen for mutant phenotypes by 
inter se crossings of G0 individuals in which the germ line has been targeted by CRISPR-Cas9. As a proof of prin-
ciple, we injected we-g3 or we-g2/we-g3 RNPs and we obtained G0 individuals to be crossed. All the surviving 
G0 flies, 20 and 38 respectively, did not show somatic mosaicism in the eyes (Supplementary Table 2; 3th and 5th 
rows). When crossed inter se, we recovered two mutant individuals out of 26 G1 flies (8%) from the we-g3 G0 
cross and three out of 184 flies (2%) from the we-g2/we-g3 G0 cross, demonstrating the feasibility of this strategy 
(Supplementary Table 4).
Sequencing of the targeted regions in 2 G1 flies of the we-g3 cross identified, as expected, mutant we alleles. 
2 out of 3 tested G1 flies of the we-g2/we-g3 cross all exhibit identical 9 bp deletion we allele at we-g3, most likely 
derived from the same G0 injected parent (Fig. 2B: we-g3). One of these 3 flies carried a large deletion of 651 bp 
resulting from duplex targeting with we-g2/we-g3 RNPs (Fig. 2B).
Cas9-induced somatic disruption of the Ceratitis paired gene. To test the functionality of purified 
Cas9 protein we established a fast in vivo assay by targeting the Ceratitis zygotic segmentation gene Ccprd, which 
is expected to give visible phenotypes in early larvae (within 3–4 days from the injections day).
We used CHOPCHOP47 to select one target sequence in Ccprd (Ccprd-g1) in a region encoding the conserved 
Paired domain (green box; Fig. 3A). Two injection rounds with Ccprd-g1 (300 mM KCl) resulted in survival 
rates of hatching embryos of 35% and 24%, respectively (Supplementary Table 5). A slightly more pronounced 
Figure 3. CRISPR-Cas9 targeting of Ccprd. (A) A scheme of the Ccprd gene and the positions and sequence 
of a sgRNA (B) Comparison of the cuticular morphology of a non-injected control (wild type) and a Ccprd-g1 
targeted embryo (prd1-Cas9). The injected embryo is significantly shorter and displays a twofold reduction 
in segment number reminiscent of the pair-rule phenotype described in Drosophila42, 43. (C) After injection 
of Ccprd-g1, high variability in phenotypes was observed ranging from wildtype appearance to strong 
deformations and size reductions along the main body axis. (D) A CrispRVariants plot of Ccprd alleles found in 
larvae developed from embryos injected with RNP containing Ccprd-g1 sgRNA.
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lethality was caused by Ccprd-g1 (larval survival rate of 0.24–0.35; Supplementary Table 5) compared to the we-g1 
and we-g2 RNPs effects (larval survival rates of 0.56 and 0.43, respectively; Supplementary Table 2). Comparing 
these values (0.24–0.35; Supplementary Table 5) to the larval survival rate of 0.46 with injection of buffer alone 
(Supplementary Table 5), RNP-mediated targeting of Ccprd led to a ∼0.1–0.2 higher mortality. Approximately 
1–5% of the injected embryos showed either delayed development (late hatching rate) or arrest at late stages of 
embryogenesis, while none of these effects were observed upon injection of Cas9 alone (data not shown). Some 
lethality was observed at larval stages, with few individuals showing impaired locomotor activity and abnormal 
cuticular morphology. Only 5–11% of injected individuals developed to adulthood, with a delay of 1–2 days com-
pared to flies injected with buffer alone or with white targeting RNPs (Supplementary Table 5).
In these 2 sets of injections, 90 embryos and 160 embryos failed to hatch into larvae, which is approximately 
90% (Supplementary Table 5) and apparently displayed disorganized cuticular/internal structures. Some were up 
to 50% shorter in size compared to control embryos and consisted of a reduced number of segments (Fig. 3B). 
Some developed into mutant larvae, which, although able to move, failed to hatch (Fig. 3C). Sequencing of indi-
viduals injected with Ccprd-g1 unveiled lesions in the targeted regions of the Ccprd locus (Fig. 3D). We con-
clude that Ccprd-g1 targeting was effective in inducing lesions in Ccprd and causing embryonic developmental 
malformations.
Discussion
Over the last two decades, novel genetic strategies in pest insect management have been developed to improve 
their effectiveness in the field. Genetic technologies used thus far in the medfly are based on random integration 
of transposable elements into the genome4, site-specific modification of the randomly integrated transgene10 and 
embryonic or transgene-mediated RNA interference (RNAi)13, 15. The disadvantage is that such genetically mod-
ified medflies must be continuously tested with respect to fitness and competitiveness as well as to stability and 
expression of the transgene9, 10. The CRISPR-Cas9 technology offers a novel approach to stably introduce exog-
enous DNA sequences at preselected locations in the genome. The use of preloaded Cas9-sgRNA complexes has 
already been successfully applied to target genes for disruption in a growing number of insect species, including 
5 dipteran28, 33, 34 and 4 lepidopteran35–38 species.
To our knowledge, this is the first report showing that the Cas9-sgRNA RNP complexes can be used to 
effectively mutate genes in a major agricultural dipteran species such as Ceratitis capitata. We report here that 
Cas9-mediated NHEJ events generate lesions in the we and Ccprd genes. Targeting the we gene caused red-white 
eye mosaicism up to 50% of injected individuals, indicating a high rate of somatic bi-allelic loss of function muta-
tions. Strong variability of somatic mosaicism was observed in the 5 injections experiments, using either single 
sgRNAs (we-1, we-2 and we-3) or in combinations (we-1/we-2 and we-2/we-3). This could be due to different 
efficiencies in target recognition of the sgRNAs, (see Supplementary Table 2). Other studies have reported success 
rates varying between 10% and 70% on a sgRNA-to-sgRNA and gene-to-gene basis30.
We demonstrated that Cas9 RNPs with we-1 or we-2, can very effectively mutate primordial germ cells with 
transmission rates up to 98–100% in 2 out of 7 crosses. To our knowledge, this germline transmission rate is the 
highest achieved in insects with purified Cas9, either commercial or lab-produced succeeding those observed in 
Drosophila (17%)28, Aedes aegypti30, 33 (in these 2 studies, respectively 21% and 90%), Anopheles funestus34 (67%), 
and Spodoptera littoralis37 (43%).
These differences in efficiency can be explained by various reasons. For example, proficiency in injecting 
embryos manually can vary greatly. Consistent delivery of a given amount of RNPs is another serious limitation 
of this technique, since manual injection of the components into the insect embryos, is technically demanding 
and has an inherently low throughput. For our injections, we used a microinjector with oil pressure to ensure a 
constant flow of the RNP mix. Lab-pulled needles, of which the tips were manually broken, generate variability in 
how much volume reaches in the embryos. The use of microinjectors with controlled pressure and standardized 
needles can help to improve reproducibility and reliability. Another important issue is stability and solubility of 
Cas9 protein, as previously observed in zebrafish39. We report here that adding KCl at 300 mM to the injection 
mix may also increase Cas9 efficiency in Ceratitis; further experiments against more targets will be needed to 
corroborate this conclusion.
As rearing insect species, like Ceratitis, is often more laborious than the model D. melanogaster, the possibility 
to screen for mutant individuals bearing 2 loss of functions alleles in G1 by crossing RNP injected individuals, is a 
very attractive solution. Our data show that we can obtain 2–8% of mutant we G1 flies, by inter se crossings of G0 
RNP-injected individuals in less than 2 months.
Several studies have reported that simultaneous use of two Cas9-sgRNAs is an effective means to generate 
deletions between the two targeted sites24, 29, 39, 48. While we-g1 and we-g2 RNPs were individually effective in 
gene editing, the absence of a deletion spanning the two targeted sites less than 100 bp apart in 4 different series 
of experiments (at 150 mM and 300 mM KCl) may be due to reciprocal steric hindrance that prevents that two 
adjacent Cas9-sgRNA complexes can cut both sites simultaneously. One study has shown that two loci separated 
by 119 bp could be cleaved simultaneously in cultured human cells but only at a low efficiency49. In contrast, 
RNPs targeting simultaneously two sites more distant from each other, such as we-g2 and we-g3 (489 bp), were 
effective in generating long deletions in both somatic and germ-line cells. Hence, it is conceivable that a multiplex 
CRISPR-Cas9 system can be used to remove, for instance, protein domains encoded by single exons in the medfly 
as long the targeted sites are more than 100 bp apart.
Furthermore, to test the activity of different Cas9 protein batches we established an in vivo assay based on tar-
geting the Ceratitis zygotic segmentation gene Ccprd. This test produces detectable phenotypes within 3 days after 
injection and presence of NHEJ lesions can be validated by subsequent sequence analysis. The segmental defects 
observed in the affected Ceratitis embryos are reminiscent of the pair-rule phenotype of Drosophila42, 43. The phe-
notypic variability is likely a result of variable proportions of wildtype cells (Ccprd+/Ccprd+ or Ccprd+/Ccprd−) 
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and mutant cells (Ccprd−/Ccprd−) in these affected individuals. The distinct shortening in length and reduction of 
segments in some individuals suggest that biallelic targeting was very effective and produced large mutant clones.
Cas9-sgRNA complexes seem to be rapidly degraded in Drosophila28, often within hours after administration; 
Cas9 protein is degraded within 24 h after being applied to cultured human cell lines17. As the short-lived activity 
of Cas9 prevents the induction of late mutational events, this may help to reduce off-target effects37, 39, 50. On the 
other side, its high efficiency may lead to biallelic mutations in most, if not all, dividing embryonic cells.
Our DNA-free method, which does not depend on delivery of Cas9 by plasmid or transgene, offers a possi-
ble solution to bypass existing regulatory restrictions that prevent the release of genetically modified organisms 
in the field. Genome modifications with the use of purified Cas9 endonuclease may be more acceptable to the 
public and considered legally legitimate by governments. As an example, with this approach novel sexing strains 
can be developed to produce male-only progeny in Ceratitis and other Tephritidae for pest control programs 
based on the sterile insect technique. This technique relies on the introduction of excessive numbers of only 
males in infested areas and hence requires large-scale sorting of males and females prior to release. In Ceratitis 
capitata and various Bactrocera species, this is achieved with the use of dominant phenotypic markers which 
are linked to the male determining Y chromosome. CRISPR-Cas9 provides an effective means to introduce new 
markers on the Y that may improve existing selections methods or even establish selection methods in species 
where no such markers were hitherto available51. Another potential application to improve of SIT is to develop a 
system that transforms genotypical females into phenotypical males. For instance, in Drosophila melanogaster a 
temperature-sensitive (ts) mutation (a single amino acid substitution) in the sex determining gene transformer-2 
exists that causes XX individuals to develop into males at the restrictive temperature52. This gene is structurally 
and functionally conserved in a wide range of insects. Transient embryonic RNAi of tra-2 in several Tephritidae 
species, including medfly8, the Mexican fly Anastrepha suspensa53 and the oriental fly Bactrocera dorsalis54 led to 
complete sexual transformation of XX individuals into phenotypically normal males. Hence, it may be feasible 
to introduce the identical mutation in tra-2 orthologs to generate ts mutants that produce male-only progeny 
following heat shocks during development. Taken together, this novel and highly effective editing technology can 
be applied to produce new and more effective strains in pest control management and, given that this technology 
is free of exogenous DNA, it may in the long term foster global acceptance regarding the release of genetically 
modified pest insects31, 55–57.
Finally, we would like to make a point that the gene targeting protocol presented in this study is simpler and 
more feasible than those published in other studies for the following reasons: (1) lab-produced Cas9 protein is sig-
nificantly cheaper than commercially available products; (2) pre-assembled Cas9 and gRNAs complexes are likely 
to be more stable in embryos than, for instance, Cas9 mRNA; (3) Cas9 mRNA production is time consuming and 
expensive, and can be stored only for few weeks, while purified Cas9 protein can be stored at −80 °C for years, 
and pre-assembled RNPs can be stored at -80 °C for at least 10 weeks without losing their activity; (4) finally, 
pre-assembled RNP complexes may have less off target effects39, 50. Our protocol and the purified Cas9 protein 
have been already successfully applied in the housefly, Musca domestica, to target the Drosophila yellow ortholog 
brown body58 and the male determining gene Mdmd59.
Our RNP-based procedure will be helpful in investigating natural traits of this major agricultural pest, for 
example invasiveness and host adaptation, reproduction, olfaction (fruit seeking behavior), chemoreception, 
toxin and insecticide metabolism60. The recent availability of the medfly genome sequence60 combined with the 
successful implementation of CRISPR genome editing technology, as reported here, opens the road to transfer 
basic knowledge to applied research. Next challenges for the CRISPR-Cas9 technology in the medfly will be to 
exploit homology-directed recombination for genome editing, either to insert transgenes in specific regions or to 
modify DNA sequences according to a co-injected template. The ability of Cas9 to perform efficient recombina-
tion at specific genomic positions will greatly advance progress towards novel genetic strategies for control of pest 
insects, such as gene drive which is based on integration of self-propagating cassettes61–64, 65.
Methods
Rearing of Ceratitis capitata. The medfly Benakeion and we strains were reared in standard laboratory 
conditions at 25 °C, 70% relative humidity and 12 h/12 h light–dark cycles. Adult flies were fed with a mixture of 
yeast and sucrose powder (1 v/2 v). Eggs were collected in dishes filled with water and after hatching transferred 
to larval food. Pupae were collected and stored in dishes until eclosion.
Following strains were used in this study: (a) the wildtype strain Benakeion which was obtained from P. A. 
Mourikis (Benakeion Institute of Phytopathology, Athens, Greece) and (b) the mutant we/we strain Benakeion4 
kindly provided by Kostas Bourtzis (Pest Control of FAO/IAEA, Seibersdorf, Austria).
Medfly larval food. 40 gr cellulose (couch paper roll), 30 g, sugar, 30 g, yeast extract, Cholesterol stock: 10 ml, 
HCl stock: 2 ml, Benzoic stock: 8,5 ml, water 400 ml.
Cholesterol stock: Cholesterol 5 g (BioChemica, AppliChem), distilled water 140 mL, ethanol 96% 50 mL 
(Carlo Erba).
HCl stock: distilled water 384 mL, HCl (37%) 66 mL (Carlo Erba). Benzoic acid stock: Benzoic acid 50 g (Carlo 
Erba), Ethanol 96% 300 mL, distilled water 150 mL.
Cas9 protein purification. We produced our own supply of Cas9 endonuclease by expressing HIS tagged 
protein in bacteria27 and following the purification protocol described in Truppo et al.45 and Dathan et al.46. The 
pET plasmid which carries the recombinant His-tagged Cas9 gene was transformed into BL21(DE3) bacterial 
strain. Protein expression was induced in presence of 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) for 
16 h at 22 °C. 100 ml cell pellet was resuspended in 10 ml of cold lysis buffer (50 mM Phosphate, 500 mM NaCl, 
10 mM Imidazole, 1 mM DTT, pH 8) supplemented with protease inhibitor mixture (1 mM PMSF and 1.0 mg/ml 
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of lysozyme) and incubated at room temperature for 30 min. Cells were disrupted by sonication on ice with 10 s 
on and 10 s off cycles for 10 min. After centrifugation at 14,000 rpm for 30 min at 4 °C, supernatant was purified by 
FPLC (AKTA) on a 1 mL His Trap HP column. The column was washed with lysis buffer and bound protein was 
eluted using a gradient from 10 mM to 500 mM imidazole. Protein elution was monitored by measuring absorb-
ance at 280 nm and resulting fractions were analyzed by 15% SDS-PAGE. The eluted fractions were dialyzed 
against buffer (20 mM HEPES, 150 mM KCl, 1 mM DTT, 10% glycerol, pH 7.5) and further purified and analyzed 
on a Superdex 200 increase 10/300 GL column.
sgRNA synthesis and RNP complex assembly. sgRNA were designed using CHOPCHOP47 https://
chopchop.rc.fas.harvard.edu/. CHOPCHOP lists the Target Sequence (including the PAM), the genomic location 
of the target, the strand (- or +), the GC content of the guide and the Off-targets. Templates for sgRNA production 
were designed as previously described25.
Oligos were obtained from Life Technologies and Sigma, as standard primers except where other-
wise noted. sgRNA DNA templates were oligo-based and obtained by PCR as previously described25 (), 
using the sgRNA forward primer (see below) for T7 templates GAAATTAATACGACTCACTATA-N19/
20-GTTTTAGAGCTAGAAATAGC (with N19/20 indicating the target site either 19 or 20 nt long) and the invar-
iant reverse p ri mer A AA AGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTT
AACTTGCTATTTCTAGCTCTAAAAC (PAGE-purified, Life Technologies).
Forward primer sequences (Cas9 target sequence is underlined):
we-g1:
GAAATTAATACGACTCACTATAGAGTAAGTGAGATTATCCGGTTTTAGAGCTAGAAATAGC
we-g2:
GAAATTAATACGACTCACTATAGCTGGTGAATCGTGTGAAGGGTTTTAGAGCTAGAAATAGC
we-g3: GAAATTAATACGACTCACTATACGGGTGAAGGGTTTATCGGGGTTTTAGAGCTAGAAATAGCC
cprd-g1: GAAATTAATACGACTCACTATAGGTCGCGTCAATCAATTAGGGTTTTAGAGCTAGAAATAGC
Primer extension was performed using Q5® High-Fidelity DNA Polymerase (NEB). The DNA template was 
cleaned by phenol/chloroform and chloroform extractions and precipitated in ethanol 70% at −20 °C overnight. 
Following centrifugation at 14,000 rpm for 15 min at 4 °C, the pellet was resuspended in 40 μl ddH2O. For syn-
thesis of sgRNA we followed the instructions of Megatranscript T7 kit (Ambion) using 400 ng of target template 
and the reaction run at 37 °C overnight, followed by ammonium acetate precipitation as per the manufacturer’s 
protocol and as described previously25, 39, 50. After RNA synthesis, DNA template was removed by incubating with 
TurboDNase (Mmessage mMACHINE T7 Ultra Kit, Ambion) for 15 min at 37 °C. Before use, all sgRNAs were 
quality-controlled on denaturing 2.5%MOPS gels.
The reaction for complex formation was prepared by mixing 1.8 µg of purified Cas9 protein with approxi-
mately 1 µg of sgRNA in a 5 μl volume containing 150 or 300 mM KCl, according to the protocols proposed by 
Lee et al.28, and Burger et al.39, respectively. The freshly prepared mixture was incubated for 10 min at 37 °C for 
pre-assembly of RNP and kept on ice prior to injections.
Microinjection of sgRNA-Cas9 RNP complexes. Embryos of the wildtype Benakeion strain were 
collected 1 hour after egg laying and chorion membrane was manually removed. Dechorionated embryos were 
aligned and glued to 3MM double side tape on a cover slip with posterior ends pointing to injection site and cov-
ered with Oil S700 (Sigma). The first injection of 240 embryos with we-g1 RNA was performed in the Bopp lab in 
Zurich University (Switzerland), using an electronic microinjector FemtoJet Eppendorf and related commercial 
needles ready to use. The remaining embryos injections were performed in Saccone lab (Naples University), with 
the following equipment and procedures: glass needles were pulled with a Narishige PB-7 and manually broken 
to produce sharp edges at the injection tip. The needle was filled with 1 μl of preloaded sgRNA-Cas9 mix and 
injected into the posterior end of embryos. A Narishige IM-9B oil microinjector was used to produce a constant 
flux of the aqueous mix.
A Leica inverted microscope DM-IRB was used for micro-injections. After injection, excess of oil was care-
fully removed and cover slips were put on an agar plate overnight at 25 °C. Surviving larvae were transferred after 
24 hours to petri dishes containing medfly larval food. A Jove video is available, describing a similar method of 
medfly embryos microinjection49.
Phenotypic analyses of mutant individuals were conducted using Leica MZ16F stereomicroscope. For the we 
targeting, we screened for red-white eye mosaicism in G0 adult flies and for white eye phenotype in G1 flies; for 
the Ccprd targeting we screened for embryonic/larval mutants in the injected G0 individuals.
Genomic analysis of Cas9-mediated DNA lesions. DNA extraction was performed, with minor mod-
ifications, according to the protocol of Holmes and Bonner66. Individual larvae or adult flies were placed in a 
1.5 ml Eppendorf tube and manually crushed with a pestle in 200 μl Holmes Bonner buffer (urea 7 M, Tris-HCl 
100 mM pH 8.0, EDTA 10 mM pH 8.0, NaCl 350 mM, SDS 2%). Subsequently, DNA was purified by phenol/
chloroform extraction, followed by chloroform extraction and ethanol precipitation. The pellet was resuspended 
in 30 μl or 100 µl water containing RNaseA. The resulting DNA was used as template to amplify the region encom-
passing the target sites, using the following primers:
F-we: GCCCTACGAGCAATCCTCT
R1-we: TCTGCAATGAGCGTCATATAC
R2-we: TTCTGCGATAGCTTTTTCAACA
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F-Ccprd: CTTCGACACACAACCGTGTG
R-Ccprd: AGAATGCTTGTGGGAATGTTCT
DreamTaq (Life Technologies) polymerase was used for PCR amplifications according to the manufacturer’s 
instructions. The PCR products were purified with StrataPrep PCR Purification Kit (Agilent Technologies) and 
subcloned using StrataClone PCR cloning Kit (Agilent Technologies). Positive clones were sequenced by Sanger 
method and ABI 310 Automated Sequencer (Applied Biosystems). CrispRVariants and panel plots were compiled 
from primary Sanger sequencing data as described in Lindsay et al.67as well as using new functionality to display 
duplex guide pairs (e.g., Fig. 1F) as implemented in the development version 1.3.6.
Data availability. All data generated or analyzed during this study are included in this published article (and 
its Supplementary Information files).
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